Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis

Ocular Immunology and Inflammation

Volumn 18, Issue 2, 2010, Pages 116-120

  Fiorelli, Vanessa M B ^a   Bhat, Pooja ^a   Stephen Foster, C ^a  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

Author keywords

Anterior uveitis; Inflammatory eye disease; Nonsteroidal anti inflammatory drugs; Recurrent uveitis

Indexed keywords

CELECOXIB; DIFLUNISAL; HLA B27 ANTIGEN;

ADULT; ARTICLE; DROWSINESS; DRUG WITHDRAWAL; DYSURIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIFLUNISAL; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; RECURRENCE; RETROSPECTIVE STUDIES; SULFONAMIDES; UVEITIS, ANTERIOR;

EID: 77950567609     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273941003587558     Document Type: Article

References (28)

1. Rothova A, van Veenendaal WG, Linssen A, Glasius E, Kijstra, de Jong PTVM. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103:137-145.
2. Gordon DM. Prednisone and prednisolone in ocular disease. Am J Ophthalmol. 1956;21:82-90.
3. Gallant C, Kenny P. Oral glucocorticoids and their complications: a review. J Am Acad Dermatol. 1986;14:161-177.
4. Soukiasian SH, Foster CS, Raizman MB. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol. 1994;118:601-611.
5. Foster CS. Medical Treatment of intermediate uveitis [review]. Dev Ophthalmol. 1992;23:156-157.
6. Tuovinen E, Esila R, Liesmaa M. Experience of the use of indomethacin in inflammatory eye diseases. Acta Ophthalmol. 1966;44:585-589.
7. Perkins ES, MacFaul PA. Indomethacin in the treatment of uveitis: a double blind trial. Trans Ophthalmol Soc UK. 1965;85:53-58.
8. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992;36:259-284.
9. Manthey KF. Nonsteroid anti-inflammatory drugs in the treatment of intermediate uveitis [review]. Dev Ophthalmol. 1992;23:158-162.
10. Melluish JW, Brooks CD, Rouff G, Cross CJ, Sanborn, EC. Ibuprofen and visual function: prospective evaluation. Arch Ophthalmol. 1975;93:781-782.
11. Rosenbaun JT, Robertson JE Jr. Recognition of posterior scleritis and its treatment with indomethacin. Retina. 1993;13:17-21.
12. March W, Coniglione TC. Ibuprofen in the treatment of uveitis. Ann Ophthalmol. 1985;17:103-104.
13. Hunter PJL, Fowler PD, Wilkinson P. Treatment of anterior uveitis: comparison of oral oxyphenbutazone and topical steroids. Br J Ophthalmol. 1973;57: 892-896.
14. Olson NY, Lindsley CB, Godfrey WA. Non-steroidal antiinflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child (US). 1988; 142:1289-1292.
15. Giordano M. Daverprophylaxe der rezidivierenden "spondylitischen iridocyclitis"durch antimalarica und nichtsteroidale antiphlogistica. Z Rheumatol. 1982;41:105-106.
16. Teasely LA, Christen GC, Foster CS. Oral non steroidal anti-inflammatory agents in the treatment of chronic or recurrent noninfectious uveitis. Contemp Ophthalmol. 2007; 6:11.
17. Samiy N, Foster CS. The role of nonsteroidal antiinflammatory drugs in ocular inflammation [review]. Int Ophthalmol Clin. 1996;36:195-206.
18. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory diseases. Am J Ophthalmol. 1987; 103: 234-235.
19. Harper SL, Chorich LJ, Foster CS.Diagnosis of uveitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002:79-103.
20. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop [review]. Am J Ophthalmol. 2005;140:509-516.
21. Almeida DR, Johnson D, Hollands H, et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg. 2008;34:64-69.
22. Vitale AT, Foster CS.Non-steroidal and anti-inflammatory drugs. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002:167-176.
23. Burne K, Glatt M, Graf P: Minireview: mechanisms of action of anti-inflammatory drugs. Gen. Pharmacol. 1976; 7:27-33.
24. Abramson SB, Weissmann G. The mechanism of action of non steroidal anti-inflammatory drugs. Arthritis Rheum. 1989; 32: 1-9.
25. Chung YM, Yeh TS, Liu JH. Clinical manifestations of HLAB27-positive acute anterior uveitis in Chinese. Chung Hua I Hsueh Tsa Chih (Taiwan). 1989; 43: 97-104.
26. Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008; 145:472-479.
27. Scheiman JM. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs [review]. Gastroenterol Clin North Am. 2009;38: 305-314.
28. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol. 2007;99: 91-98.